Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025

Use of nootropics in Alzheimer’s disease: An analysis of regulatory positions and drug policies in the countries of the Commonwealth of Independent States

Elvira Grigorievna Alexandrova, Tatyana Rudolfovna Abakumova, Liliya Eugenevna Ziganshina

International Journal of Risk & Safety in Medicine

Retricted access

Review article

First published 2013-1-10

Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes

Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer

Journal of Alzheimer’s Disease

Retricted access

Review article

First published 2012-11-14

Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer

Journal of Alzheimer’s Disease

Retricted access

Review article

First published 2014-7-25

Cognitive Enhancers (Nootropics). Part 1: Drugs interacting with Receptors. Update 2014

Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer

Journal of Alzheimer’s Disease

Retricted access

Review article

First published 2013-2-6

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs

Journal of Alzheimer’s Disease

Open access

Research article

First published 2015-12

Anti-stress and nootropic activity of drugs affecting the renin-angiotensin system in rats based on indirect biochemical evidence

KV Anil Kumar, Shrasti Nagwar, Rama Thyloor [...]

Journal of the Renin-Angiotensin-Aldosterone System

Retricted access

Research article

First published 1984-10

Pharmacotherapy of Memory Loss in the Geriatric Patient

Virginia J. Galizia

Annals of Pharmacotherapy

Open access

Review article

First published 2025-3

The Effect of Psoralea corylifolia (Babchi) on Neuronal Apoptosis Induced by Palmitate in PC12 Cells and its Role in Alzheimer’s Disease: A Review

Sachin Ranjan, Nidhi Singh Kushwaha, Shalini Trivedi [...]

Pharmacognosy Magazine

Retricted access

Review article

First published 2014-8-11

Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014

Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer

Journal of Alzheimer’s Disease

Retricted access

Review article

First published 2014-10-10

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs

Journal of Alzheimer’s Disease

Search results